KC
TCBPW

Kepos Capital’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Kepos Capital’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-470,588
Closed -$5K – 71
2024
Q4 		$5K Hold
470,588
– – ﹤0.01% 52
2024
Q3 		$9K Hold
470,588
– – ﹤0.01% 210
2024
Q2 		$6K Hold
470,588
– – ﹤0.01% 213
2024
Q1 		$9K Hold
470,588
– – ﹤0.01% 235
2023
Q4 		$15K Hold
470,588
– – ﹤0.01% 190
2023
Q3 		$10K Hold
470,588
– – ﹤0.01% 240
2023
Q2 		$20K Buy
+470,588
New +$29.6K ﹤0.01% 285
2022
Q4 		$66K Hold
470,588
– – 0.01% 227
2022
Q3 		$109K Hold
470,588
– – 0.01% 223
2022
Q2 		$95K Hold
470,588
– – 0.01% 266
2022
Q1 		$231K Buy
+470,588
New +$219K 0.02% 304

Kepos Capital's TCBPW Position: Q1 2025 in Review

Kepos Capital sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q1 2025, closing a stake of 470,588 shares — an estimated $5K sold.

Kepos Capital first reported a position in TCBPW in Q1 2022 and held it in 11 quarters. The position peaked at $231K in Q1 2022. 0 funds tracked by Wall St. Rank hold TCBPW as of Q1 2025.

  • Kepos Capital reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q1 2025 after selling out during the quarter.
  • Kepos Capital sold 470,588 TC BioPharm (Holdings) plc Warrants shares in Q1 2025, an estimated $5K.
  • Kepos Capital first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and held it in 11 quarters.
  • Kepos Capital's TC BioPharm (Holdings) plc Warrants position peaked at $231K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q1 2025.

Based on Kepos Capital's 13F filing for Q1 2025, filed 13 May 2025.